1002 related articles for article (PubMed ID: 22185738)
1. Pathophysiology of hereditary angioedema.
Zuraw BL; Christiansen SC
Am J Rhinol Allergy; 2011; 25(6):373-8. PubMed ID: 22185738
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis and laboratory diagnosis of hereditary angioedema.
Zuraw BL; Christiansen SC
Allergy Asthma Proc; 2009; 30(5):487-92. PubMed ID: 19843402
[TBL] [Abstract][Full Text] [Related]
3. Current update on cellular and molecular mechanisms of hereditary angioedema.
Walford HH; Zuraw BL
Ann Allergy Asthma Immunol; 2014 May; 112(5):413-8. PubMed ID: 24484972
[TBL] [Abstract][Full Text] [Related]
4. Hereditary angioedema: management of laryngeal attacks.
Christiansen SC; Zuraw BL
Am J Rhinol Allergy; 2011; 25(6):379-82. PubMed ID: 22185739
[TBL] [Abstract][Full Text] [Related]
5. Bradykinin-mediated diseases.
Kaplan AP
Chem Immunol Allergy; 2014; 100():140-7. PubMed ID: 24925394
[TBL] [Abstract][Full Text] [Related]
6. New insights into hereditary angio-oedema: Molecular diagnosis and therapy.
Nagy N; Grattan CE; McGrath JA
Australas J Dermatol; 2010 Aug; 51(3):157-62. PubMed ID: 20695852
[TBL] [Abstract][Full Text] [Related]
7. The pathophysiology of hereditary angioedema.
Davis AE
Clin Immunol; 2005 Jan; 114(1):3-9. PubMed ID: 15596403
[TBL] [Abstract][Full Text] [Related]
8. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
Zeerleder S; Levi M
Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
[TBL] [Abstract][Full Text] [Related]
9. Treatment of laryngeal hereditary angioedema.
Richman MJ; Talan DA; Lumry WR
J Emerg Med; 2012 Jan; 42(1):44-7. PubMed ID: 21315535
[TBL] [Abstract][Full Text] [Related]
10. Hereditary angioedema with F12 mutation: factors modifying the clinical phenotype.
Charignon D; Ghannam A; Defendi F; Ponard D; Monnier N; López Trascasa M; Launay D; Caballero T; Djenouhat K; Fain O; Cichon S; Martin L; Drouet C
Allergy; 2014 Dec; 69(12):1659-65. PubMed ID: 25134986
[TBL] [Abstract][Full Text] [Related]
11. The bradykinin-forming cascade and its role in hereditary angioedema.
Kaplan AP; Joseph K
Ann Allergy Asthma Immunol; 2010 Mar; 104(3):193-204. PubMed ID: 20377108
[TBL] [Abstract][Full Text] [Related]
12. Mutational spectrum of the C1INH (SERPING1) gene in patients with hereditary angioedema.
Gösswein T; Kocot A; Emmert G; Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Bork K; Oldenburg J; Müller CR
Cytogenet Genome Res; 2008; 121(3-4):181-8. PubMed ID: 18758157
[TBL] [Abstract][Full Text] [Related]
13. Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade.
Busse P; Kaplan A
J Allergy Clin Immunol Pract; 2022 Mar; 10(3):716-722. PubMed ID: 34838707
[TBL] [Abstract][Full Text] [Related]
14. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
[TBL] [Abstract][Full Text] [Related]
15. The pathogenesis of hereditary angioedema.
Davis AE
Transfus Apher Sci; 2003 Dec; 29(3):195-203. PubMed ID: 14572810
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy.
Kaplan AP
J Allergy Clin Immunol; 2010 Nov; 126(5):918-25. PubMed ID: 20889195
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of hereditary angioedema.
Canonica GW; Rossi O
Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
[TBL] [Abstract][Full Text] [Related]
18. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
Joseph K; Tholanikunnel TE; Kaplan AP
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
20. Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate.
Nielsen EW; Gramstad S
Acta Anaesthesiol Scand; 2006 Jan; 50(1):120-2. PubMed ID: 16451161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
